Here are the highlights on Brazil’s tech and business scene in July:
July 30
Facebook selects ten social impact startups for acceleration. The program, in partnership with the accelerator Artemisia, lasts six months and targets businesses with the potential to improve the lives of low-income citizens.
July 23
Latin America faces a unique opportunity to develop the next generation of tech startup stars. The funding record can be partially explained by the appearance of mega rounds in the region.
July 18
Investors from around the globe are flocking to Latin America — within the first half of 2018. Deals and dollars to private tech companies in Latin America hit a high of $1.35B in 2017. Brazil closed most deals and raised most money because of the mega-rounds above $100M.
July 18
Brazil’s BNDES selected DOMO Invest to manage its angel co-investment fund, which will invest up to R$100m over the next ten years.
July 12
Brazil was already the hottest spot for technology investment throughout Latin America. With this new investment, Naspers and its co-investors have invested a total of $375 million into Movile, putting the company close to $1 billion valuation.
July 11
Canary made an undisclosed investment in Go Good, a healthtech startup. Canary is a venture capital created by the founders of Peixe Urbano and Printi and with the participation of notable entrepreneurs of startups like Instagram, Nubank, VivaReal, GuiaBolso and 99.
July 5
SEBRAE will invest R$ 45 million in small business innovators through five funds selected by the institution.
July 4
Brazil to grow as tech hub over the next 5 to 10 years, according to DST Global investor. The country accounted for most of Latin America’s $1bn in VC investments last year.
July 2
The diagnostic medicine labs Fleury and Sabin entered into a partnership to invest in startups in the health area. The companies made an initial US$ 2 million contribution to Qure, a venture capital owned by the Israeli investment fund OurCrown, to accelerate small businesses with projects linked to diagnostic medicine.
